Table 3.
Laboratory comparisons between women and men with normal body mass index and obesity
| Women | Men | ||||||
|---|---|---|---|---|---|---|---|
| Normal BMI (n = 28) |
Obesity (n = 35) | p-value | Normal BMI (n = 9) |
Obesity (n = 13) | p-value | ||
| Fasting plasma glucose | 78.16 ± 5.85 | 86.43 ± 13.98 | 0.002 | 81.57 ± 10.18 | 94.70 ± 12.00 | 0.030 | |
| HbA1c, % | 5.2 ± 0.3 | 5.7 ± 0.3 | < 0.001 | 5.2 ± 0.2 | 5.8 ± 0.3 | < 0.001 | |
| HOMA-IR | 1.75 ± 0.68 | 3.12 ± 1.28 | < 0.001 | 1.71 ± 1.00 | 2.91 ± 1.71 | 0.056 | |
| hs-CRP, mg/L | 0.43 (0.81) | 3.63 (5.73) | < 0.001* | 0.74 ± 0.42 | 5.43 ± 4.77 | 0.010 | |
| ADMA, ng/mL | 630.68 ± 133.96 | 727.81 ± 165.52 | 0.011 | 621.65 ± 125.97 | 688.77 ± 151.97 | 0.258 | |
| MOTS-C, pg/mL | 14.42 ± 3.37 | 14.36 ± 3.84 | 0.797 | 10.99 ± 2.21 | 14.25 ± 3.73 | 0.112 | |
*
Mann-Whitney U test.
Results expressed as mean ± standard deviation or median (interval interquartile).
BMI: body mass index; HbA1c: glycated hemoglobin; HOMA: Homeostatic Model Assessment Insulin Resistance; hs-CRP: high-sensitivity C-reactive protein; ADMA: asymmetric dimethylarginine.